The prevalence of mtDNA4977 deletion in primary human endometrial carcinomas and matched control samples

  • Authors:
    • Konrad Futyma
    • Lechoslaw Putowski
    • Marek Cybulski
    • Pawel Miotla
    • Tomasz Rechberger
    • Andrzej Semczuk
  • View Affiliations

  • Published online on: September 1, 2008     https://doi.org/10.3892/or_00000060
  • Pages: 683-688
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

mtDNA4977, the most common deletion of the mitochondrial DNA, has been detected in different types of human neoplasia. The aim of the current study was to determine the prevalence of mtDNA4977 deletion in primary human endometrial carcinomas (EC) as compared with matched control samples. Thirty-seven matched control tissues and EC samples were enrolled, and the 4977-bp mtDNA deletion was investigated using a PCR-based technique. Deletion of mtDNA4977 was detected in 32 out of 37 (84%) matched control samples and in 30 out of 37 (81%) ECs. A statistically significant correlation of mtDNA4977/wild-type mtDNA ratios was noted between normal and cancerous human endometrial tissues (R=0.844, p<0.0001). The intensity ratio of mtDNA bands was significantly higher in normal samples than in malignant human endometrial tissues (p=0.021). The mean mtDNA4977/wild-type mtDNA ratio was significantly higher in the control group (0.655±0.379) than in the cancer group (0.570±0.04, p=0.048) of patients between 50 and 60 years of age. Notably, there was a relationship between clinical stage of the disease (stage II versus III) and the amount of mtDNA4977 in ECs (p=0.048). The sequence analysis of two randomly selected EC-positive cases confirmed that amplified fragments originated from mtDNA, and both encompassed deletion. In conclusion, we suggest that mitochondrial 4977-bp deletion is not specific to EC tissues. The accumulation of mtDNA4977 may be associated with aging processes, particularly in peri-menopausal women affected by EC.

Related Articles

Journal Cover

September 2008
Volume 20 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Futyma K, Putowski L, Cybulski M, Miotla P, Rechberger T and Semczuk A: The prevalence of mtDNA4977 deletion in primary human endometrial carcinomas and matched control samples. Oncol Rep 20: 683-688, 2008
APA
Futyma, K., Putowski, L., Cybulski, M., Miotla, P., Rechberger, T., & Semczuk, A. (2008). The prevalence of mtDNA4977 deletion in primary human endometrial carcinomas and matched control samples. Oncology Reports, 20, 683-688. https://doi.org/10.3892/or_00000060
MLA
Futyma, K., Putowski, L., Cybulski, M., Miotla, P., Rechberger, T., Semczuk, A."The prevalence of mtDNA4977 deletion in primary human endometrial carcinomas and matched control samples". Oncology Reports 20.3 (2008): 683-688.
Chicago
Futyma, K., Putowski, L., Cybulski, M., Miotla, P., Rechberger, T., Semczuk, A."The prevalence of mtDNA4977 deletion in primary human endometrial carcinomas and matched control samples". Oncology Reports 20, no. 3 (2008): 683-688. https://doi.org/10.3892/or_00000060